

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.52736633 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.52736633 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.23403557 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.23403557 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.78595963 |
| 6 | tryptophan catabolic process (GO:0006569) | 6.18582063 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.18582063 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.18582063 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.10100405 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.04727390 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.87493952 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.81244705 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.80032482 |
| 14 | cysteine metabolic process (GO:0006534) | 5.61027154 |
| 15 | urea cycle (GO:0000050) | 5.52424593 |
| 16 | urea metabolic process (GO:0019627) | 5.52424593 |
| 17 | epoxygenase P450 pathway (GO:0019373) | 5.43749518 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.41442864 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.37377390 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.33548941 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30093674 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.18221929 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.12726974 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.11983323 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.11924014 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10793391 |
| 27 | protein carboxylation (GO:0018214) | 5.10793391 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.07906232 |
| 29 | bile acid metabolic process (GO:0008206) | 4.98483186 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.96166471 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.95948087 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92308047 |
| 33 | lysine metabolic process (GO:0006553) | 4.87964003 |
| 34 | lysine catabolic process (GO:0006554) | 4.87964003 |
| 35 | regulation of complement activation (GO:0030449) | 4.78009709 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.71877356 |
| 37 | omega-hydroxylase P450 pathway (GO:0097267) | 4.68068095 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.67121483 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.67106447 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.65804677 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.64822033 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.63145059 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.56835752 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56225427 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.56225427 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.56225427 |
| 47 | triglyceride homeostasis (GO:0070328) | 4.55666259 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.55666259 |
| 49 | drug catabolic process (GO:0042737) | 4.51962957 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.50642591 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.50642591 |
| 52 | glycine metabolic process (GO:0006544) | 4.46245030 |
| 53 | phospholipid efflux (GO:0033700) | 4.41024197 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.40651828 |
| 55 | cellular glucuronidation (GO:0052695) | 4.37319449 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.36657613 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.35175815 |
| 58 | glutamate metabolic process (GO:0006536) | 4.30212436 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.29213646 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.26793975 |
| 61 | cellular biogenic amine catabolic process (GO:0042402) | 4.26618202 |
| 62 | amine catabolic process (GO:0009310) | 4.26618202 |
| 63 | drug metabolic process (GO:0017144) | 4.25767047 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.23022740 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.21811871 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.19253798 |
| 67 | serine family amino acid biosynthetic process (GO:0009070) | 4.17870754 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.14156852 |
| 69 | ethanol oxidation (GO:0006069) | 4.11179487 |
| 70 | cholesterol efflux (GO:0033344) | 4.05076435 |
| 71 | exogenous drug catabolic process (GO:0042738) | 4.03855452 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99400154 |
| 73 | ketone body metabolic process (GO:1902224) | 3.98459010 |
| 74 | aldehyde catabolic process (GO:0046185) | 3.97018443 |
| 75 | oxidative demethylation (GO:0070989) | 3.94393092 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.91446449 |
| 77 | glucuronate metabolic process (GO:0019585) | 3.91446449 |
| 78 | arginine metabolic process (GO:0006525) | 3.89803470 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 3.88581545 |
| 80 | phenylpropanoid metabolic process (GO:0009698) | 3.87288669 |
| 81 | regulation of cholesterol homeostasis (GO:2000188) | 3.85649338 |
| 82 | drug transmembrane transport (GO:0006855) | 3.83607303 |
| 83 | fibrinolysis (GO:0042730) | 3.83577521 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 3.82227134 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80710624 |
| 86 | urate metabolic process (GO:0046415) | 3.80289946 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.75738495 |
| 88 | organic acid catabolic process (GO:0016054) | 3.75738495 |
| 89 | flavonoid metabolic process (GO:0009812) | 3.75586223 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74977967 |
| 91 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.74906157 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.74906157 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.74418532 |
| 94 | phospholipid homeostasis (GO:0055091) | 3.72374771 |
| 95 | intestinal absorption (GO:0050892) | 3.72254306 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.71831828 |
| 97 | sterol homeostasis (GO:0055092) | 3.69310416 |
| 98 | cofactor catabolic process (GO:0051187) | 3.65455108 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64391320 |
| 100 | aspartate family amino acid catabolic process (GO:0009068) | 3.60971474 |
| 101 | positive regulation of lipid catabolic process (GO:0050996) | 3.60921303 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.60689202 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.58605048 |
| 104 | complement activation, classical pathway (GO:0006958) | 3.57609574 |
| 105 | response to nitrosative stress (GO:0051409) | 3.56042090 |
| 106 | cytolysis (GO:0019835) | 3.55132425 |
| 107 | polyketide metabolic process (GO:0030638) | 3.45576955 |
| 108 | doxorubicin metabolic process (GO:0044598) | 3.45576955 |
| 109 | daunorubicin metabolic process (GO:0044597) | 3.45576955 |
| 110 | heme transport (GO:0015886) | 3.42974816 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.41503833 |
| 112 | regulation of plasminogen activation (GO:0010755) | 3.35345657 |
| 113 | S-adenosylmethionine metabolic process (GO:0046500) | 3.34852767 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.33623716 |
| 115 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.30746587 |
| 116 | primary alcohol catabolic process (GO:0034310) | 3.29658969 |
| 117 | ethanol metabolic process (GO:0006067) | 3.28192062 |
| 118 | negative regulation of blood coagulation (GO:0030195) | 3.15167776 |
| 119 | negative regulation of hemostasis (GO:1900047) | 3.15167776 |
| 120 | xenobiotic catabolic process (GO:0042178) | 3.14478289 |
| 121 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.12008636 |
| 122 | negative regulation of coagulation (GO:0050819) | 3.11512012 |
| 123 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09537973 |
| 124 | drug transport (GO:0015893) | 3.08459185 |
| 125 | alkaloid metabolic process (GO:0009820) | 3.07494006 |
| 126 | negative regulation of protein activation cascade (GO:2000258) | 2.99987144 |
| 127 | protein-lipid complex subunit organization (GO:0071825) | 2.92918410 |
| 128 | negative regulation of wound healing (GO:0061045) | 2.90895004 |
| 129 | quinone metabolic process (GO:1901661) | 2.90134897 |
| 130 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.87284123 |
| 131 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.87284123 |
| 132 | vitamin biosynthetic process (GO:0009110) | 2.85575078 |
| 133 | protein-lipid complex assembly (GO:0065005) | 2.85562513 |
| 134 | xenobiotic metabolic process (GO:0006805) | 2.83545214 |
| 135 | cholesterol transport (GO:0030301) | 2.79550330 |
| 136 | sterol transport (GO:0015918) | 2.79550330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.33518113 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20385692 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.88450918 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47507357 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19106259 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03775384 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.95438069 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95095479 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.94854732 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.84176791 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.70341472 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38478504 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30286629 |
| 14 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.19771017 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03965265 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01643833 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8658395 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82627003 |
| 19 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68747430 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67341377 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64642467 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63182298 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61272822 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.58494759 |
| 25 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.54244790 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51237251 |
| 27 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49750872 |
| 28 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.48255785 |
| 29 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.46139263 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45959525 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45691154 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35104958 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33433291 |
| 34 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31480748 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31451487 |
| 36 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.31013816 |
| 37 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.31013816 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26676998 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25401104 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24765419 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24579654 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23401815 |
| 43 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22486380 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22331984 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.21489367 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.19142138 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18831705 |
| 48 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18248818 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18140565 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17348713 |
| 51 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16593826 |
| 52 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16262610 |
| 53 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.16174453 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13769571 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.13279243 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13114357 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13114357 |
| 58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12793295 |
| 59 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.10142755 |
| 60 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09485288 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09070066 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08880235 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08450283 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07316969 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06968933 |
| 66 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.06838860 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06802511 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06532193 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05927229 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05187047 |
| 71 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04785279 |
| 72 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04785279 |
| 73 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02379385 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00473389 |
| 75 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00195322 |
| 76 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99633992 |
| 77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99578940 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98107587 |
| 79 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97983425 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97577109 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96703512 |
| 82 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96530449 |
| 83 | ERA_21632823_ChIP-Seq_H3396_Human | 0.95513440 |
| 84 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.95140206 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94608727 |
| 86 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94042579 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94022350 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93601554 |
| 89 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93565731 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93305723 |
| 91 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92136093 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91786424 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91579786 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91555913 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.88304858 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84860656 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83447955 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82962347 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81993856 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81670589 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.80774905 |
| 102 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80068974 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79293588 |
| 104 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78315430 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76717408 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74937580 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74728838 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74447679 |
| 109 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73962603 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73429164 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.73373309 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.73063468 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71252674 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70968041 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70633165 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.66059726 |
| 117 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64002756 |
| 118 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62883798 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61919424 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.61437452 |
| 121 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60127744 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59958851 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59084158 |
| 124 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58114170 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58114170 |
| 126 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57062870 |
| 127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.56724754 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54418123 |
| 129 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53637603 |
| 130 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53558344 |
| 131 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52806731 |
| 132 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52254054 |
| 133 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51192056 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50765644 |
| 135 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50614199 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47775101 |
| 137 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47061293 |
| 138 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.46881230 |
| 139 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45569354 |
| 140 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45191258 |
| 141 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44022774 |
| 142 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43809092 |
| 143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.43560966 |
| 144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42418821 |
| 145 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.42406727 |
| 146 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41589071 |
| 147 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.41014467 |
| 148 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40823810 |
| 149 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39895404 |
| 150 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.39733409 |
| 151 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39244010 |
| 152 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.39153187 |
| 153 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38739321 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37958352 |
| 155 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37730473 |
| 156 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.37166438 |
| 157 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36864312 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.36725234 |
| 159 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36652226 |
| 160 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.35743494 |
| 161 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.35741229 |
| 162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35320102 |
| 163 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35115103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.19857364 |
| 2 | MP0005360_urolithiasis | 7.89298932 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36220803 |
| 4 | MP0005365_abnormal_bile_salt | 6.04660037 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00622395 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.35272541 |
| 7 | MP0003252_abnormal_bile_duct | 3.93936942 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.48461153 |
| 9 | MP0009840_abnormal_foam_cell | 3.15764177 |
| 10 | MP0005083_abnormal_biliary_tract | 3.01414178 |
| 11 | MP0005332_abnormal_amino_acid | 2.91683424 |
| 12 | MP0003195_calcinosis | 2.79678349 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.77942365 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.40772881 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.38597965 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.23030010 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.12114994 |
| 18 | MP0000609_abnormal_liver_physiology | 2.09804988 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.03460192 |
| 20 | MP0003868_abnormal_feces_composition | 1.92325799 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.83127149 |
| 22 | MP0001764_abnormal_homeostasis | 1.61413006 |
| 23 | MP0005451_abnormal_body_composition | 1.56471116 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55149834 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.44357131 |
| 26 | MP0009697_abnormal_copulation | 1.44339246 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.43067782 |
| 28 | MP0003011_delayed_dark_adaptation | 1.34729300 |
| 29 | MP0000427_abnormal_hair_cycle | 1.32307781 |
| 30 | MP0003186_abnormal_redox_activity | 1.31217052 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.24424584 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.23604717 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.20211957 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.19894561 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.16999002 |
| 36 | MP0000383_abnormal_hair_follicle | 1.15708376 |
| 37 | MP0000598_abnormal_liver_morphology | 1.15179483 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.10531033 |
| 39 | MP0000566_synostosis | 1.10195928 |
| 40 | MP0001873_stomach_inflammation | 1.09617495 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.09238938 |
| 42 | MP0005647_abnormal_sex_gland | 1.01685215 |
| 43 | MP0003183_abnormal_peptide_metabolism | 0.98538358 |
| 44 | MP0009764_decreased_sensitivity_to | 0.98203122 |
| 45 | MP0002160_abnormal_reproductive_system | 0.98196238 |
| 46 | MP0002254_reproductive_system_inflammat | 0.97345122 |
| 47 | MP0000604_amyloidosis | 0.97308485 |
| 48 | MP0005379_endocrine/exocrine_gland_phen | 0.95582670 |
| 49 | MP0009763_increased_sensitivity_to | 0.95008970 |
| 50 | MP0005408_hypopigmentation | 0.93723815 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.92422317 |
| 52 | MP0003943_abnormal_hepatobiliary_system | 0.92299399 |
| 53 | MP0004147_increased_porphyrin_level | 0.90222047 |
| 54 | MP0001944_abnormal_pancreas_morphology | 0.89844132 |
| 55 | MP0002938_white_spotting | 0.88772026 |
| 56 | MP0009642_abnormal_blood_homeostasis | 0.85446586 |
| 57 | MP0005670_abnormal_white_adipose | 0.84681154 |
| 58 | MP0008469_abnormal_protein_level | 0.84666917 |
| 59 | MP0003122_maternal_imprinting | 0.82536672 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.81072320 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 0.80035208 |
| 62 | MP0005376_homeostasis/metabolism_phenot | 0.78204197 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.77141349 |
| 64 | MP0010368_abnormal_lymphatic_system | 0.77070215 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.76240781 |
| 66 | MP0001756_abnormal_urination | 0.75196463 |
| 67 | MP0003950_abnormal_plasma_membrane | 0.74785762 |
| 68 | MP0002876_abnormal_thyroid_physiology | 0.74001352 |
| 69 | MP0001529_abnormal_vocalization | 0.73951612 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 0.73359348 |
| 71 | MP0001664_abnormal_digestion | 0.73165717 |
| 72 | MP0003283_abnormal_digestive_organ | 0.72746366 |
| 73 | MP0004133_heterotaxia | 0.71221878 |
| 74 | MP0005389_reproductive_system_phenotype | 0.69873617 |
| 75 | MP0001324_abnormal_eye_pigmentation | 0.69400958 |
| 76 | MP0001919_abnormal_reproductive_system | 0.67488761 |
| 77 | MP0009053_abnormal_anal_canal | 0.67470104 |
| 78 | MP0001661_extended_life_span | 0.66981547 |
| 79 | MP0002971_abnormal_brown_adipose | 0.66178904 |
| 80 | MP0005266_abnormal_metabolism | 0.64978413 |
| 81 | MP0005187_abnormal_penis_morphology | 0.63645012 |
| 82 | MP0005334_abnormal_fat_pad | 0.63210605 |
| 83 | MP0000647_abnormal_sebaceous_gland | 0.63151828 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.62784484 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.61299596 |
| 86 | MP0005535_abnormal_body_temperature | 0.61138422 |
| 87 | MP0003890_abnormal_embryonic-extraembry | 0.59583857 |
| 88 | MP0004130_abnormal_muscle_cell | 0.58491631 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.58453121 |
| 90 | MP0005645_abnormal_hypothalamus_physiol | 0.58084167 |
| 91 | MP0003936_abnormal_reproductive_system | 0.57786694 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.57673697 |
| 93 | MP0003329_amyloid_beta_deposits | 0.56375411 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.54139421 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.53718804 |
| 96 | MP0005448_abnormal_energy_balance | 0.53393916 |
| 97 | MP0002102_abnormal_ear_morphology | 0.53388485 |
| 98 | MP0003718_maternal_effect | 0.53093875 |
| 99 | MP0000462_abnormal_digestive_system | 0.51860486 |
| 100 | MP0005395_other_phenotype | 0.51460475 |
| 101 | MP0003123_paternal_imprinting | 0.51333151 |
| 102 | MP0002751_abnormal_autonomic_nervous | 0.51281256 |
| 103 | MP0005410_abnormal_fertilization | 0.51224931 |
| 104 | MP0001881_abnormal_mammary_gland | 0.51195881 |
| 105 | MP0004043_abnormal_pH_regulation | 0.50865500 |
| 106 | MP0002928_abnormal_bile_duct | 0.50706065 |
| 107 | MP0003690_abnormal_glial_cell | 0.50308729 |
| 108 | MP0005253_abnormal_eye_physiology | 0.49754472 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.48201989 |
| 110 | MP0005666_abnormal_adipose_tissue | 0.47891550 |
| 111 | MP0003638_abnormal_response/metabolism_ | 0.47638351 |
| 112 | MP0002089_abnormal_postnatal_growth/wei | 0.47178925 |
| 113 | MP0005195_abnormal_posterior_eye | 0.46202077 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.45703109 |
| 115 | MP0002822_catalepsy | 0.44445738 |
| 116 | MP0008873_increased_physiological_sensi | 0.44112917 |
| 117 | MP0003937_abnormal_limbs/digits/tail_de | 0.43911597 |
| 118 | MP0003724_increased_susceptibility_to | 0.43519807 |
| 119 | MP0008872_abnormal_physiological_respon | 0.43338483 |
| 120 | MP0002796_impaired_skin_barrier | 0.43196336 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.43089369 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.42778159 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.42469459 |
| 124 | MP0003953_abnormal_hormone_level | 0.40907013 |
| 125 | MP0005166_decreased_susceptibility_to | 0.40245069 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.39711029 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.38707185 |
| 128 | MP0008874_decreased_physiological_sensi | 0.37517346 |
| 129 | MP0009384_cardiac_valve_regurgitation | 0.37079790 |
| 130 | MP0009672_abnormal_birth_weight | 0.36499225 |
| 131 | MP0000579_abnormal_nail_morphology | 0.33626038 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.33512652 |
| 133 | MP0003436_decreased_susceptibility_to | 0.33292627 |
| 134 | MP0003075_altered_response_to | 0.33096747 |
| 135 | MP0005248_abnormal_Harderian_gland | 0.32499745 |
| 136 | MP0002168_other_aberrant_phenotype | 0.32113425 |
| 137 | MP0009115_abnormal_fat_cell | 0.30988036 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.30461340 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.29700053 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.28872589 |
| 141 | MP0000249_abnormal_blood_vessel | 0.28544052 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.28485765 |
| 143 | MP0002970_abnormal_white_adipose | 0.28249556 |
| 144 | MP0002060_abnormal_skin_morphology | 0.27833295 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.27674226 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.27395378 |
| 147 | MP0004883_abnormal_blood_vessel | 0.27185896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.20354504 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19361105 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.01401912 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47340114 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.23261784 |
| 6 | Xanthomatosis (HP:0000991) | 6.14632145 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.09813681 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.08297514 |
| 9 | Complement deficiency (HP:0004431) | 5.08074060 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.71823789 |
| 11 | Hyperammonemia (HP:0001987) | 4.61617824 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57795307 |
| 13 | Joint hemorrhage (HP:0005261) | 4.46340787 |
| 14 | Hyperglycinemia (HP:0002154) | 4.46172687 |
| 15 | Epidermoid cyst (HP:0200040) | 4.35023991 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29470293 |
| 17 | Ketosis (HP:0001946) | 4.28717286 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25737172 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.25686671 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20453501 |
| 21 | Hyperglycinuria (HP:0003108) | 4.19605403 |
| 22 | Fat malabsorption (HP:0002630) | 4.16061402 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 4.11961663 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.10111738 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.10111738 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 4.05969516 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.95751983 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78517314 |
| 29 | Abnormality of complement system (HP:0005339) | 3.74918070 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74290814 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55969295 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.44053456 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40866770 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29213996 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.27272470 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26244647 |
| 37 | Ketoacidosis (HP:0001993) | 3.18697763 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.12520888 |
| 39 | Steatorrhea (HP:0002570) | 3.05532618 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.04562337 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.03099083 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.97137403 |
| 43 | Gout (HP:0001997) | 2.97022843 |
| 44 | Metabolic acidosis (HP:0001942) | 2.89711324 |
| 45 | Spontaneous abortion (HP:0005268) | 2.83754077 |
| 46 | Abnormality of the renal cortex (HP:0011035) | 2.80658146 |
| 47 | Myocardial infarction (HP:0001658) | 2.79281148 |
| 48 | Lethargy (HP:0001254) | 2.74697799 |
| 49 | Vascular calcification (HP:0004934) | 2.71805366 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.70531255 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.70531255 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.69150811 |
| 53 | Skin nodule (HP:0200036) | 2.65345631 |
| 54 | Acanthocytosis (HP:0001927) | 2.59657852 |
| 55 | Pancreatic cysts (HP:0001737) | 2.58393309 |
| 56 | Potter facies (HP:0002009) | 2.56059890 |
| 57 | Facial shape deformation (HP:0011334) | 2.56059890 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.56013216 |
| 59 | Spastic diplegia (HP:0001264) | 2.51773080 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.50866739 |
| 61 | Malnutrition (HP:0004395) | 2.50755534 |
| 62 | Abnormal gallbladder physiology (HP:0012438) | 2.50461099 |
| 63 | Cholecystitis (HP:0001082) | 2.50461099 |
| 64 | Cerebral edema (HP:0002181) | 2.50000648 |
| 65 | Hypothermia (HP:0002045) | 2.48825248 |
| 66 | Pigmentary retinal degeneration (HP:0001146) | 2.44853311 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.42207556 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.40068326 |
| 69 | Cholelithiasis (HP:0001081) | 2.37201654 |
| 70 | Irritability (HP:0000737) | 2.36733387 |
| 71 | Fair hair (HP:0002286) | 2.34047588 |
| 72 | Neonatal onset (HP:0003623) | 2.33237060 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.28879277 |
| 74 | Esophageal varix (HP:0002040) | 2.25752232 |
| 75 | Hyperphosphaturia (HP:0003109) | 2.24932771 |
| 76 | Late onset (HP:0003584) | 2.24367210 |
| 77 | Glomerulonephritis (HP:0000099) | 2.24083773 |
| 78 | Proximal tubulopathy (HP:0000114) | 2.22449766 |
| 79 | Alkalosis (HP:0001948) | 2.21148998 |
| 80 | Hyperuricemia (HP:0002149) | 2.19394848 |
| 81 | Increased purine levels (HP:0004368) | 2.19394848 |
| 82 | Vomiting (HP:0002013) | 2.18090979 |
| 83 | J-shaped sella turcica (HP:0002680) | 2.17873392 |
| 84 | Mitral stenosis (HP:0001718) | 2.16032272 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.15880762 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.15880762 |
| 87 | Sensorimotor neuropathy (HP:0007141) | 2.15093699 |
| 88 | Pancreatitis (HP:0001733) | 2.14970535 |
| 89 | Rickets (HP:0002748) | 2.14783410 |
| 90 | Enlarged kidneys (HP:0000105) | 2.14315139 |
| 91 | Type II lissencephaly (HP:0007260) | 2.13885440 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.13157449 |
| 93 | Abnormality of alanine metabolism (HP:0010916) | 2.10376999 |
| 94 | Hyperalaninemia (HP:0003348) | 2.10376999 |
| 95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10376999 |
| 96 | Gingival bleeding (HP:0000225) | 2.08859995 |
| 97 | Amyloidosis (HP:0011034) | 2.05765818 |
| 98 | Bile duct proliferation (HP:0001408) | 2.05585515 |
| 99 | Abnormal biliary tract physiology (HP:0012439) | 2.05585515 |
| 100 | Brushfield spots (HP:0001088) | 2.05408683 |
| 101 | Glycosuria (HP:0003076) | 2.05270734 |
| 102 | Abnormality of urine glucose concentration (HP:0011016) | 2.05270734 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03168131 |
| 104 | Concave nail (HP:0001598) | 2.01579956 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 2.01433855 |
| 106 | Opisthotonus (HP:0002179) | 2.00552687 |
| 107 | Tubular atrophy (HP:0000092) | 1.99570144 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 1.99102302 |
| 109 | Chorioretinal atrophy (HP:0000533) | 1.98892192 |
| 110 | Menorrhagia (HP:0000132) | 1.98491733 |
| 111 | Thrombophlebitis (HP:0004418) | 1.97371322 |
| 112 | Abnormality of the nasal septum (HP:0000419) | 1.97329779 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.95272552 |
| 114 | Poikilocytosis (HP:0004447) | 1.95268565 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.94724408 |
| 116 | Arthropathy (HP:0003040) | 1.92346041 |
| 117 | Hemorrhage of the eye (HP:0011885) | 1.91156219 |
| 118 | Azoospermia (HP:0000027) | 1.90119032 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.89281433 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.87016520 |
| 121 | Large for gestational age (HP:0001520) | 1.86912923 |
| 122 | Abnormality of the vitreous humor (HP:0004327) | 1.83859473 |
| 123 | Megaloblastic anemia (HP:0001889) | 1.83497302 |
| 124 | Amelogenesis imperfecta (HP:0000705) | 1.82995208 |
| 125 | Pendular nystagmus (HP:0012043) | 1.82924275 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81391092 |
| 127 | Generalized hypopigmentation of hair (HP:0011358) | 1.81386952 |
| 128 | True hermaphroditism (HP:0010459) | 1.79197502 |
| 129 | Cystic liver disease (HP:0006706) | 1.78733706 |
| 130 | Renal cortical cysts (HP:0000803) | 1.77689785 |
| 131 | Pancreatic fibrosis (HP:0100732) | 1.76243036 |
| 132 | Cerebellar dysplasia (HP:0007033) | 1.75809683 |
| 133 | Abnormality of vitamin B metabolism (HP:0004340) | 1.72719527 |
| 134 | Nephritis (HP:0000123) | 1.72266074 |
| 135 | Congenital stationary night blindness (HP:0007642) | 1.71320836 |
| 136 | Molar tooth sign on MRI (HP:0002419) | 1.70804247 |
| 137 | Abnormality of midbrain morphology (HP:0002418) | 1.70804247 |
| 138 | Hyperventilation (HP:0002883) | 1.70195583 |
| 139 | Reduced antithrombin III activity (HP:0001976) | 1.69844610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.03042731 |
| 2 | FGFR4 | 4.36751511 |
| 3 | ERN1 | 4.13889017 |
| 4 | SIK1 | 4.07199523 |
| 5 | ERBB4 | 3.36854822 |
| 6 | STK39 | 3.20172888 |
| 7 | TAOK3 | 2.88387359 |
| 8 | MST1R | 2.83779265 |
| 9 | INSRR | 2.67402521 |
| 10 | PKN2 | 2.57778365 |
| 11 | MAP3K12 | 2.28129776 |
| 12 | BMPR1B | 2.26965076 |
| 13 | MAPK11 | 2.01224058 |
| 14 | MST4 | 2.01173218 |
| 15 | MAPKAPK3 | 1.97262726 |
| 16 | MUSK | 1.95905595 |
| 17 | STK38L | 1.95093177 |
| 18 | MAP2K4 | 1.94400250 |
| 19 | FLT3 | 1.87642586 |
| 20 | MAP4K2 | 1.84819115 |
| 21 | FRK | 1.84167006 |
| 22 | TRIB3 | 1.83623791 |
| 23 | ADRBK2 | 1.83338242 |
| 24 | LATS1 | 1.83095355 |
| 25 | CASK | 1.80054295 |
| 26 | PIK3CG | 1.69495521 |
| 27 | PTK6 | 1.67382277 |
| 28 | LMTK2 | 1.57311624 |
| 29 | EIF2AK1 | 1.55153182 |
| 30 | TRIM28 | 1.54940140 |
| 31 | ZAK | 1.50821612 |
| 32 | TYK2 | 1.49138541 |
| 33 | ABL2 | 1.42456524 |
| 34 | EIF2AK3 | 1.40738242 |
| 35 | TNIK | 1.37397670 |
| 36 | BRSK2 | 1.35695126 |
| 37 | GRK6 | 1.32075498 |
| 38 | NEK9 | 1.31583690 |
| 39 | DAPK2 | 1.26066436 |
| 40 | FER | 1.23188799 |
| 41 | MAP3K7 | 1.22863059 |
| 42 | KDR | 1.22468932 |
| 43 | ERBB2 | 1.20835470 |
| 44 | MAP3K3 | 1.14923421 |
| 45 | MET | 1.12475746 |
| 46 | PRKAA2 | 1.12313274 |
| 47 | BCR | 1.10254091 |
| 48 | FGFR2 | 1.09125006 |
| 49 | TLK1 | 1.09083452 |
| 50 | MAP3K10 | 1.07789750 |
| 51 | JAK2 | 1.06554086 |
| 52 | PBK | 1.06003935 |
| 53 | TBK1 | 1.00823432 |
| 54 | PRKCE | 0.97490831 |
| 55 | RPS6KB2 | 0.94408284 |
| 56 | PRKCI | 0.92631021 |
| 57 | CDK8 | 0.91360955 |
| 58 | MAP2K3 | 0.89299852 |
| 59 | PNCK | 0.88954499 |
| 60 | MAP3K14 | 0.87666497 |
| 61 | MAPK4 | 0.87031100 |
| 62 | PRKCZ | 0.86878641 |
| 63 | RIPK1 | 0.84622863 |
| 64 | CDK6 | 0.80877357 |
| 65 | ERBB3 | 0.80732406 |
| 66 | PINK1 | 0.80198712 |
| 67 | MAPK15 | 0.80077737 |
| 68 | FGFR1 | 0.80041882 |
| 69 | JAK1 | 0.79788364 |
| 70 | WNK3 | 0.78876453 |
| 71 | MAP2K6 | 0.77064344 |
| 72 | WNK4 | 0.76579069 |
| 73 | CHUK | 0.76207288 |
| 74 | PAK3 | 0.75605811 |
| 75 | MAP3K11 | 0.75442243 |
| 76 | EPHB1 | 0.74617080 |
| 77 | DYRK1B | 0.74567848 |
| 78 | GSK3A | 0.74315348 |
| 79 | PRKACG | 0.73384515 |
| 80 | PTK2 | 0.72861500 |
| 81 | PRKAA1 | 0.71767258 |
| 82 | PRKCG | 0.70771690 |
| 83 | TSSK6 | 0.70472055 |
| 84 | NME1 | 0.70278254 |
| 85 | EPHA2 | 0.69426826 |
| 86 | PHKG1 | 0.68118906 |
| 87 | PHKG2 | 0.68118906 |
| 88 | ADRBK1 | 0.66160180 |
| 89 | CAMK2G | 0.64108120 |
| 90 | MYLK | 0.64042993 |
| 91 | MAP2K1 | 0.63762460 |
| 92 | MAP2K2 | 0.61967832 |
| 93 | LIMK1 | 0.61333496 |
| 94 | CSK | 0.60894647 |
| 95 | CAMK2D | 0.60808601 |
| 96 | WEE1 | 0.60552131 |
| 97 | TIE1 | 0.58457420 |
| 98 | NEK6 | 0.57819917 |
| 99 | TESK2 | 0.55147298 |
| 100 | NEK1 | 0.53837166 |
| 101 | STK3 | 0.53345882 |
| 102 | MAPK12 | 0.52795511 |
| 103 | DAPK1 | 0.51948877 |
| 104 | EPHA3 | 0.51609273 |
| 105 | OXSR1 | 0.50812520 |
| 106 | SGK3 | 0.50405512 |
| 107 | EPHA4 | 0.50283814 |
| 108 | MAPKAPK5 | 0.49621110 |
| 109 | PDPK1 | 0.48954290 |
| 110 | IRAK3 | 0.47014553 |
| 111 | PDK4 | 0.46628852 |
| 112 | PDK3 | 0.46628852 |
| 113 | MAPK13 | 0.46345026 |
| 114 | NUAK1 | 0.44579871 |
| 115 | MAP2K7 | 0.44423030 |
| 116 | RPS6KB1 | 0.44185004 |
| 117 | NTRK3 | 0.44029395 |
| 118 | TGFBR2 | 0.43041126 |
| 119 | CAMK1D | 0.42886790 |
| 120 | CDK4 | 0.42044264 |
| 121 | CSNK1D | 0.41299700 |
| 122 | MAP3K4 | 0.41272919 |
| 123 | PRKCQ | 0.40845270 |
| 124 | TAF1 | 0.40026926 |
| 125 | GRK1 | 0.39926199 |
| 126 | IGF1R | 0.38973523 |
| 127 | CSNK1E | 0.38973491 |
| 128 | CSNK1G1 | 0.38657857 |
| 129 | PRKG2 | 0.38561392 |
| 130 | ILK | 0.38331305 |
| 131 | CSNK1A1 | 0.38218043 |
| 132 | AKT3 | 0.37177236 |
| 133 | BMX | 0.36675870 |
| 134 | CDK7 | 0.36378450 |
| 135 | MAPK7 | 0.35521654 |
| 136 | MTOR | 0.35422667 |
| 137 | ICK | 0.34546641 |
| 138 | PIK3CA | 0.33838977 |
| 139 | MKNK2 | 0.33660302 |
| 140 | CSF1R | 0.33347921 |
| 141 | IKBKE | 0.32710212 |
| 142 | MAP3K5 | 0.32121281 |
| 143 | PRKCA | 0.32072044 |
| 144 | LATS2 | 0.31143064 |
| 145 | PRKACA | 0.31129561 |
| 146 | EGFR | 0.31067816 |
| 147 | CSNK2A1 | 0.30586572 |
| 148 | SGK494 | 0.29960046 |
| 149 | SGK223 | 0.29960046 |
| 150 | TAOK2 | 0.29753721 |
| 151 | FGFR3 | 0.29702235 |
| 152 | CSNK1A1L | 0.29642225 |
| 153 | MAP3K2 | 0.29071448 |
| 154 | RET | 0.28919757 |
| 155 | STK38 | 0.28224499 |
| 156 | ACVR1B | 0.28181958 |
| 157 | MAP3K1 | 0.27244481 |
| 158 | PDK1 | 0.27181904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.28631575 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48386816 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.47026360 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26216676 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95477379 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70681177 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66339361 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57464850 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56859264 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51581312 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50710376 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43508733 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34476629 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25431370 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13121163 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07336761 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96334350 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94226331 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90545258 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90117763 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83130616 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83060399 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77913742 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74111154 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72563264 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71508675 |
| 27 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67437005 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.66736826 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.64764666 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62532270 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61670046 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61387818 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56993030 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.55114138 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52503899 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50275499 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47276688 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43906612 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39672431 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39162648 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33596319 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28831606 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28793151 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26369279 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26053733 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24321117 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23721450 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18666886 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14357978 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.13564576 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12107174 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02488919 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00624981 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98991560 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94833777 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94079841 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92408171 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87533958 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84856790 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.84853266 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.83949590 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80443762 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79490224 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78286423 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75012178 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73523183 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72574179 |
| 68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65370477 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64178058 |
| 70 | Protein export_Homo sapiens_hsa03060 | 0.57057966 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49221904 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.48218648 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.44633609 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43392765 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40274469 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39983111 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39390890 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.38642306 |
| 79 | RNA polymerase_Homo sapiens_hsa03020 | 0.35857837 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32627908 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29624121 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.26391995 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22815586 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19575530 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.18705472 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.17709997 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17662398 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17127545 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.13976758 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13773548 |
| 91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.09859046 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08770084 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.08722573 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06761449 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05330712 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02681048 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00435962 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.2524224 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2457676 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | -0.2035344 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2032496 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1912968 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1871741 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1685572 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1678613 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1517402 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1460620 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1325781 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1307427 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1139423 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1082713 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1080697 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1019491 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0954576 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | -0.0738732 |
| 116 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0260564 |

